Watch to learn about Trial Interactive’s comprehensive approach to supporting Sponsors and CROs of all sizes.
#}
From Author to Archive
Your Perfect-Fit Platform to Simplify Clinical Content Management and Oversight.
From site identification to close-out, clinical document processes and operational oversight are complex. Our electronic trial solutions simplify your clinical operations: expedite timelines, enable collaboration, improve quality, capture the full story of study, and pass inspections.
“Trial Interactive has helped us enable a critical piece of remote trial management: visibility into all documents needed to remotely oversee a clinical trial. We only touch documents once because documents flow seamlessly between GlobalLearn, the eISF, and the eTMF. With Trial Interactive, we help studies lower risk and achieve near real-time oversight, without site visits.”
Penelope Manasco, MD, CEO, MANA RBM
“We were up and running in two weeks with Trial Interactive. This also coincided with a 48-hour MHRA approval after final protocol submission, Our CRO/Sponsor team and partnership with Trial Interactive made it possible to expedite this critical, time-sensitive research.”
Thomas Ogorka, Founder and CEO, Orphan Reach
“Web based portal solutions have been identified as a critical imperative for achieving new gains in adverse event management efficiency. Our collaboration with Trial Interactive has produced a fully compliant safety portal platform to enhance workflow efficiency. We believe this is a breakthrough approach our respective client base will find compelling under a wide variety of applications.”
Michael O'Gorman, President and General Manager, Sentrx
"They get all the little details of the work that we do."
Senior Director, CRO
Latest from our leadership
Experience Award-Winning Technology
The Enterprise Path to Inspection Readiness
Create, review, and archive clinical content. Launch compliance focused training. Index all required records in the eTMF
All within one system
Make it easy to show the story of your study to regulatory agencies.
